Savient Pharmaceuticals Files Voluntary Chapter 11 Proceeding
October 14, 2013 at 21:40 PM EDT
Savient Pharmaceuticals (NASDAQ: SVNT ) announced today that it has elected to file voluntary petitions under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware (the "Court"). Savient also filed a motion seeking authorization to pursue a sale process under Section 363
